A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion.
Also in this 12-page issue: GM Cancer Research Foundation awards annual prizes to four scientists.
Age-adjusted cancer incidence and mortality down slightly, annual report finds.
Bills in House, Senate, would give FDA authority over tobacco products.
Surgeon General’s report adds to list of smoking-related cancers, other diseases.
ASCO honors physicians for clinical trials participation.
President’s Cancer Panel urges comprehensive health care reform, provision of services for cancer survivors.
Funding opportunities listed.
Trending Stories
- Backlog of work grows at NIH as staff members are being hounded to quit
- In the Headlines: What are Jay Bhattacharya’s plans for NIH?
- Rathmell: My mentor recognized a cliff I was going to fall off before I did.
“He was there to stand with me while I fell, and then made me look up and see that I needed to lean into the experience.” - The Directors: Ray DuBois and Roy Jensen on how COE guides cancer care in rural America
“We’re just going to have to ride through this and not give up.” - In support of three coordinated CCSG components reducing our national burden of cancer
- In the Headlines: Could “flooding the zone” drown NIH and cancer centers?
